TPD & Induced Proximity Summit Leaderboard
  • Saturday, July 4, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 317

Author

Pharma Journalist 8916 posts 0 comments

Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United…

Dec 9, 2021
Rapid Dose Therapeutics Corp. a Canadian biotechnology company revolutionizing drug delivery through innovation, entered into an agreement on Friday, November 26, 2021 with Oakland…
Read More...

Syndax Pharmaceuticals Announces Closing of Global Collaboration and License Agreement for…

Dec 9, 2021
Syndax Pharmaceuticals, Inc. announced that the Hart-Scott-Rodino (HSR) antitrust waiting period had expired and that the parties closed the exclusive worldwide collaboration and…
Read More...

Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in…

Dec 9, 2021
Prestige BioPharma Ltd. and Dr. Reddy’s Laboratories Ltd. announced that the two companies have entered into a binding agreement for an exclusive partnership for the supply and…
Read More...

Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US…

Dec 9, 2021
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the US for the…
Read More...

Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First…

Dec 9, 2021
Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced that the…
Read More...

Thermo Fisher Scientific Completes Acquisition of PPD

Dec 9, 2021
Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. for $17.4 billion. "We are very excited to officially welcome our PPD colleagues to Thermo…
Read More...

NeurOp Receives FDA Orphan Drug Designation for NP10679 for Treatment of Subarachnoid Hemorrhage

Dec 8, 2021
NeurOp, Inc., a clinical-stage biotechnology company focused on neurological and psychiatric disorders, announced that the U.S. Food and Drug Administration (FDA) has granted orphan…
Read More...

PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases

Dec 8, 2021
PacBio and the UCLA Institute for Precision Health and David Geffen School of Medicine at UCLA have formed a research collaboration to further identify the causes of rare diseases. The…
Read More...

GenScript ProBio Opens China’s Largest Commercial GMP Plasmid Manufacturing Facility

Dec 8, 2021
GenScript ProBio announced the opening of China's largest commercial GMP plasmid manufacturing facility during a ceremony at the site in Zhenjiang, Jiangsu Province. The…
Read More...

Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19…

Dec 8, 2021
Arbutus Biopharma Corporation, X-Chem, Inc. (X-Chem) and Proteros biostructures GmbH (Proteros) announced that Arbutus Biopharma has identified several molecules that inhibit the…
Read More...
Prev Next
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Arcturus Partners With Thermo Fisher on Cystic Fibrosis mRNA Therapy
  • Lonza Secures Nona’s BBB Technology for CNS Drug Development
  • Ipsen Acquires Memo Therapeutics to Advance BK Virus Treatment
  • AlzeCure Licenses Alzheimer’s Drug Candidate ACD856 in $2.2B Deal
  • Inocras, AimedBio Partner to Advance ADC Precision Oncology Development

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.